Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; AIDS Drug Assistance Program Data Report ADR, OMB No. 0915-0345-Revision, 19494-19495 [2020-07247]
Download as PDF
<![CDATA[
19494
ACTION:
Federal Register / Vol. 85, No. 67 / Tuesday, April 7, 2020 / Notices
Notice of supplemental award.
HRSA’s HIV/AIDS Bureau
will award $100,000 in supplemental
funding to the University of
Washington. This award is to support
the Ryan White HIV/AIDS Program Part
F AIDS Education and Training Centers
(AETC) Enhancement and Update of the
National HIV Curriculum e-Learning
Platform project in Fiscal Year (FY)
2020 and in each succeeding year of
their periods of performance, pending
the availability of funds. This
supplemental funding will enable the
University of Washington to make
critical content enhancements to the
National HIV Curriculum e-Learning
Platform that respond to the specific
training and technical assistance needs
of HIV treatment professionals located
in the jurisdictions targeted by the
Ending the HIV Epidemic: A Plan for
America (EHE) initiative. Further, it will
ensure that more health professionals in
EHE jurisdictions have access to the
most up-to-date HIV treatment
interventions and protocols, thus
increasing their competency to provide
high-quality care for people with HIV
and in so doing, advance the goals of the
EHE.
FOR FURTHER INFORMATION CONTACT:
Sherrillyn Crooks, Chief, HIV Education
Branch, Office of Training and Capacity
Development, HRSA, 5600 Fishers Lane,
Room 9N110, Rockville, MD 20857, by
email at scrooks@hrsa.gov or by phone
at (301) 443–7662.
SUPPLEMENTARY INFORMATION:
Intended Recipient of the Award: The
University of Washington, AETC
Enhancement and Update of the
National HIV Curriculum e-Learning
Platform project.
Amount of Award: $100,000 available
in FY 2020.
Project Period: March 1, 2020–August
31, 2022.
CFDA Number: 93.145.
Authority: 42 U.S.C. 300ff–111(a)
(section 2692(a) of the Public Health
Service (PHS) Act), 42 U.S.C. 300ff–121
(section 2693 of the PHS Act), and
Further Consolidated Appropriations
Act, 2020 (Pub. L. 116–94).
Justification: The University of
Washington currently manages the
AETC’s web-based National HIV
Curriculum-e-Learning Platform. The
National HIV Curriculum e-Learning
Platform provides virtual state of the art
training and resources to HIV treatment
and care professionals. The recipient
will use this supplement award to
enhance the quality and relevance of the
of training and technical assistance
resources offered through the National
HIV Curriculum e-Learning Platform
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:22 Apr 06, 2020
Jkt 250001
and expand its focus to include the
specific educational needs of HIV care
and treatment providers in EHE
designated areas. The supplemental
funds will enable the University of
Washington to deploy more robust
outreach efforts that target EHE
jurisdictions to ensure that they are
aware of and can use this valuable webbased resource. Engaging new and
experienced HIV providers and health
professions training institutions in EHE
regions will allow the University of
Washington to better discern and
directly respond to any training needs
or gaps these providers and institutions
may identify. Expanding the availability
of state-of-the-art HIV care and
treatment training resources will help
prepare for the projected increase in
demand for well-trained HIV care
professionals as a result of the EHE
rollout. This award recipient has the
demonstrated expertise and scalable
experience required to address these
time-sensitive technical and training
assistance.
Thomas J. Engels,
Administrator.
[FR Doc. 2020–07214 Filed 4–6–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request; AIDS Drug Assistance
Program Data Report ADR, OMB No.
0915–0345—Revision
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with of the
Paperwork Reduction Act of 1995,
HRSA has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period.
DATES: Comments on this ICR should be
received no later than May 7, 2020.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
SUMMARY:
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email Lisa
Wright-Solomon, the HRSA Information
Collection Clearance Officer at
paperwork@hrsa.gov or call (301) 443–
1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
AIDS Drug Assistance Program Data
Report (ADAP) OMB No. 0915–0345—
Revisions.
Abstract: HRSA’s Ryan White HIV/
AIDS Program AIDS Drug Assistance
Program (RWHAP ADAP) is authorized
under Part B of the RWHAP legislation,
codified in sections 2611 et seq. of the
Public Health Service Act, which
provides grants to U.S. states and
territories. HRSA’s RWHAP ADAP is a
state and territory-administered program
that provides Food and Drug
Administration-approved medications
to low-income people with HIV who
have limited or no health coverage from
private insurance, Medicaid, or
Medicare. HRSA’s RWHAP ADAP funds
may also be used to purchase health
insurance for eligible clients and for
services that enhance access, adherence,
and monitoring of drug treatments.
All 50 states, the District of Columbia,
Puerto Rico, Guam, the U.S. Virgin
Islands, and the five U.S. Pacific
Territories or Associated Jurisdictions
receive RWHAP Part B grant awards
including funds for RWHAP ADAP.
RWHAP Part B reporting requirements
include the annual submission of an
ADAP Data Report (ADR), including a
Recipient Report and a Client Report.
The Recipient Report is a collection of
basic information about grant recipient
characteristics and policies including
program administration, purchasing
mechanisms, funding, and
expenditures. The Client Report is a
collection of client-level records (one
record for each client enrolled in the
RWHAP ADAP), which includes the
client’s encrypted unique identifier,
basic demographic data, enrollment
information, services received and
clinical data.
HRSA is proposing several changes to
the ADR Recipient and Client Reports to
improve question clarity, delete obsolete
data elements, combine related data
elements, add new data elements, and
improve response options to reflect
program practices and support HRSA’s
analysis and understanding of program
impact. In addition, a new initiative,
E:\FR\FM\07APN1.SGM
07APN1
19495
Federal Register / Vol. 85, No. 67 / Tuesday, April 7, 2020 / Notices
Ending the HIV Epidemic: A Plan for
America (EHE), began in Fiscal Year
2020 and some of its data collection
requirements will be incorporated in
existing annual data collections,
including the ADR, in order to limit
recipient burden. Specifically, the
Recipient Report includes the following
proposed changes:
• Addition of two new ‘‘Yes/No’’
questions
• addition of one new follow-up
question that requests the number of
new clients enrolled
• addition of one question on funding
to monitor the use of funds provided to
ADAPs for the EHE initiative
• clarification on two existing
questions
• revision to one existing question
that requests program income and
manufacturer rebates reinvested in
ADAP, and
• deletion of six obsolete data
elements.
The Client Report includes the
following proposed changes:
• Revision to reporting of RWHAP
ADAP-funded medications to include
all medications rather than a subset of
medications;
• revision to one existing question
that requests reporting of all RWHAP
ADAP-funded medications using the
National Drug Code from the Drug
Identification Code (d-codes);
• revision to reporting of clinical data
for clients to include all clients rather
than a subset of clients; and
• deletion of three data elements that
were combined with other existing data
elements.
New and revised data elements
require reporting of information that
should already be collected by
recipients to meet legislative or
programmatic requirements for the
proper oversight and administration of
the program.
A 60-day notice was published in the
Federal Register on December 3, 2019,
vol. 84, No. 232; pp. 66202–03. There
were two public comments. Both
comments were requests to clarify the
data reporting changes, which included
requests for a copy of the ADR
instrument.
Need and Proposed Use of the
Information: HRSA’s RWHAP requires
the submission of annual reports by the
Secretary of Department of Health and
Human Services to the appropriate
committees of Congress. HRSA uses the
ADR to evaluate the national impact of
the HRSA RWHAP ADAP by providing
client-level data on individuals being
served, services being delivered, and
costs associated with these services. The
client-level data is used to monitor
health outcomes of people with HIV
receiving care and treatment through the
HRSA RWHAP ADAP, to monitor the
use of HRSA RWHAP ADAP funds in
addressing the HIV epidemic and its
impact on vulnerable communities, and
to track progress toward achieving the
goals identified in the National HIV/
AIDS Strategy.
Likely Respondents: State ADAPs of
RWHAP Part B recipients.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
Recipient Report ..................................................................
Client-Level Report ..............................................................
54
54
1
1
54
54
6
81
324
4,374
Total ..............................................................................
* 54
........................
54
........................
4,698
Maria G. Button,
Director, Executive Secretariat.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2020–07247 Filed 4–6–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses
per
respondent
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
VerDate Sep<11>2014
18:22 Apr 06, 2020
Jkt 250001
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel NIDCR Secondary and
Genomic Data Analysis Application Review
Meeting.
Date: July 1, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental and
Craniofacial Research, National Institutes of
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Health, 6701 Democracy Boulevard, Suite
668, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nisan Bhattacharyya,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute of Dental
and Craniofacial Research, National Institutes
of Health, 6701 Democracy Boulevard, Suite
668, Bethesda, MD 20892, 301–451–2405,
nisan_bhattacharyya@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: April 1, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–07192 Filed 4–6–20; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\07APN1.SGM
07APN1
]]>Agencies
[Federal Register Volume 85, Number 67 (Tuesday, April 7, 2020)]
[Notices]
[Pages 19494-19495]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07247]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission to OMB for
Review and Approval; Public Comment Request; AIDS Drug Assistance
Program Data Report ADR, OMB No. 0915-0345--Revision
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with of the Paperwork Reduction Act of 1995,
HRSA has submitted an Information Collection Request (ICR) to the
Office of Management and Budget (OMB) for review and approval. Comments
submitted during the first public review of this ICR will be provided
to OMB. OMB will accept further comments from the public during the
review and approval period.
DATES: Comments on this ICR should be received no later than May 7,
2020.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance
requests submitted to OMB for review, email Lisa Wright-Solomon, the
HRSA Information Collection Clearance Officer at [email protected] or
call (301) 443-1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title: AIDS Drug Assistance Program
Data Report (ADAP) OMB No. 0915-0345--Revisions.
Abstract: HRSA's Ryan White HIV/AIDS Program AIDS Drug Assistance
Program (RWHAP ADAP) is authorized under Part B of the RWHAP
legislation, codified in sections 2611 et seq. of the Public Health
Service Act, which provides grants to U.S. states and territories.
HRSA's RWHAP ADAP is a state and territory-administered program that
provides Food and Drug Administration-approved medications to low-
income people with HIV who have limited or no health coverage from
private insurance, Medicaid, or Medicare. HRSA's RWHAP ADAP funds may
also be used to purchase health insurance for eligible clients and for
services that enhance access, adherence, and monitoring of drug
treatments.
All 50 states, the District of Columbia, Puerto Rico, Guam, the
U.S. Virgin Islands, and the five U.S. Pacific Territories or
Associated Jurisdictions receive RWHAP Part B grant awards including
funds for RWHAP ADAP. RWHAP Part B reporting requirements include the
annual submission of an ADAP Data Report (ADR), including a Recipient
Report and a Client Report. The Recipient Report is a collection of
basic information about grant recipient characteristics and policies
including program administration, purchasing mechanisms, funding, and
expenditures. The Client Report is a collection of client-level records
(one record for each client enrolled in the RWHAP ADAP), which includes
the client's encrypted unique identifier, basic demographic data,
enrollment information, services received and clinical data.
HRSA is proposing several changes to the ADR Recipient and Client
Reports to improve question clarity, delete obsolete data elements,
combine related data elements, add new data elements, and improve
response options to reflect program practices and support HRSA's
analysis and understanding of program impact. In addition, a new
initiative,
[[Page 19495]]
Ending the HIV Epidemic: A Plan for America (EHE), began in Fiscal Year
2020 and some of its data collection requirements will be incorporated
in existing annual data collections, including the ADR, in order to
limit recipient burden. Specifically, the Recipient Report includes the
following proposed changes:
Addition of two new ``Yes/No'' questions
addition of one new follow-up question that requests the
number of new clients enrolled
addition of one question on funding to monitor the use of
funds provided to ADAPs for the EHE initiative
clarification on two existing questions
revision to one existing question that requests program
income and manufacturer rebates reinvested in ADAP, and
deletion of six obsolete data elements.
The Client Report includes the following proposed changes:
Revision to reporting of RWHAP ADAP-funded medications to
include all medications rather than a subset of medications;
revision to one existing question that requests reporting
of all RWHAP ADAP-funded medications using the National Drug Code from
the Drug Identification Code (d-codes);
revision to reporting of clinical data for clients to
include all clients rather than a subset of clients; and
deletion of three data elements that were combined with
other existing data elements.
New and revised data elements require reporting of information that
should already be collected by recipients to meet legislative or
programmatic requirements for the proper oversight and administration
of the program.
A 60-day notice was published in the Federal Register on December
3, 2019, vol. 84, No. 232; pp. 66202-03. There were two public
comments. Both comments were requests to clarify the data reporting
changes, which included requests for a copy of the ADR instrument.
Need and Proposed Use of the Information: HRSA's RWHAP requires the
submission of annual reports by the Secretary of Department of Health
and Human Services to the appropriate committees of Congress. HRSA uses
the ADR to evaluate the national impact of the HRSA RWHAP ADAP by
providing client-level data on individuals being served, services being
delivered, and costs associated with these services. The client-level
data is used to monitor health outcomes of people with HIV receiving
care and treatment through the HRSA RWHAP ADAP, to monitor the use of
HRSA RWHAP ADAP funds in addressing the HIV epidemic and its impact on
vulnerable communities, and to track progress toward achieving the
goals identified in the National HIV/AIDS Strategy.
Likely Respondents: State ADAPs of RWHAP Part B recipients.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install, and utilize technology and
systems for the purpose of collecting, validating, and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this ICR are summarized in the table below.
Total Estimated Annualized Burden--Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Number of responses per Total per response Total burden
respondents respondent responses (in hours) hours
----------------------------------------------------------------------------------------------------------------
Recipient Report................ 54 1 54 6 324
Client-Level Report............. 54 1 54 81 4,374
-------------------------------------------------------------------------------
Total....................... * 54 .............. 54 .............. 4,698
----------------------------------------------------------------------------------------------------------------
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-07247 Filed 4-6-20; 8:45 am]
BILLING CODE 4165-15-P
